These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 21793027)

  • 1. Prevention of recurrence after resection of hepatocellular carcinoma: a daunting challenge.
    Poon RT
    Hepatology; 2011 Sep; 54(3):757-9. PubMed ID: 21793027
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of vitamin K2 on the recurrence of hepatocellular carcinoma.
    Yoshida H; Shiratori Y; Kudo M; Shiina S; Mizuta T; Kojiro M; Yamamoto K; Koike Y; Saito K; Koyanagi N; Kawabe T; Kawazoe S; Kobashi H; Kasugai H; Osaki Y; Araki Y; Izumi N; Oka H; Tsuji K; Toyota J; Seki T; Osawa T; Masaki N; Ichinose M; Seike M; Ishikawa A; Ueno Y; Tagawa K; Kuromatsu R; Sakisaka S; Ikeda H; Kuroda H; Kokuryu H; Yamashita T; Sakaida I; Katamoto T; Kikuchi K; Nomoto M; Omata M
    Hepatology; 2011 Aug; 54(2):532-40. PubMed ID: 21574174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical application of vitamin K for hepatocellular carcinoma].
    Mizuta T; Ozaki I
    Clin Calcium; 2007 Nov; 17(11):1693-9. PubMed ID: 17982189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of vitamin K2 in preventing the recurrence of hepatocellular carcinoma after curative treatment: a meta-analysis of randomized controlled trials.
    Riaz IB; Riaz H; Riaz T; Rahman S; Amir M; Badshah MB; Kazi AN
    BMC Gastroenterol; 2012 Nov; 12():170. PubMed ID: 23191943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of vitamin K2 on the recurrence in patients with hepatocellular carcinoma.
    Hotta N; Ayada M; Sato K; Ishikawa T; Okumura A; Matsumoto E; Ohashi T; Kakumu S
    Hepatogastroenterology; 2007; 54(79):2073-7. PubMed ID: 18251162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re: Interferon: the magic bullet to prevent hepatocellular carcinoma recurrence after resection?
    Sun HC; Zhang W
    Ann Surg; 2008 May; 247(5):900; author reply 900-1. PubMed ID: 18438131
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of vitamin K2 on the development of hepatocellular carcinoma in type C cirrhosis.
    Kojima K; Tamano M; Akima T; Hashimoto T; Kuniyoshi T; Maeda C; Majima Y; Kusano K; Murohisa T; Iijima M; Hiraishi H
    Hepatogastroenterology; 2010; 57(102-103):1264-7. PubMed ID: 21410069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin K deficiency and hepatocellular carcinoma.
    Piquet MA; Hourmand-Ollivier I; Dao T
    JAMA; 2004 Dec; 292(21):2580-1; author reply 2581. PubMed ID: 15572713
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiviral therapy after curative resection for patients with hepatitis B-related hepatocellular carcinoma.
    Chong CC; Lai PB
    Br J Surg; 2013 May; 100(6):724-5. PubMed ID: 23475744
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatocellular carcinoma and vitamin K.
    Mizuta T; Ozaki I
    Vitam Horm; 2008; 78():435-42. PubMed ID: 18374204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comprehensive prevention and treatment of recurrence for hepatocellular carcinoma after hepatectomy].
    Xia Y; Shen F
    Zhonghua Gan Zang Bing Za Zhi; 2013 May; 21(5):326-8. PubMed ID: 24052959
    [No Abstract]   [Full Text] [Related]  

  • 12. How do we conquer the recurrence of HCC?
    Nouso K
    J Gastroenterol; 2015 Jun; 50(6):703-4. PubMed ID: 25330977
    [No Abstract]   [Full Text] [Related]  

  • 13. Adjuvant iodine-131-labeled lipiodol for prevention of intrahepatic recurrence of hepatocellular carcinoma: which is the best treatment schedule?
    Tabone M; Vigano L; Laudi C; Ferrero A; Pellerito R; Capussotti L
    Hepatology; 2005 Jun; 41(6):1433; author reply 1433-4. PubMed ID: 15834934
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of new hepatocellular carcinoma with concomitant antiviral therapy in chronic hepatitis B patients whose initial tumor was successfully ablated.
    Hann HW; Bergin D; Coben R; DiMarino AJ
    Int J Cancer; 2011 Feb; 128(3):739-42. PubMed ID: 20473872
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthetic retinoids for the secondary prevention of hepatocellular carcinoma.
    Shafritz DA
    N Engl J Med; 1996 Jun; 334(24):1600-1. PubMed ID: 8628344
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of vitamin K2 in the development of hepatocellular carcinoma in women with viral cirrhosis of the liver.
    Habu D; Shiomi S; Tamori A; Takeda T; Tanaka T; Kubo S; Nishiguchi S
    JAMA; 2004 Jul; 292(3):358-61. PubMed ID: 15265851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatocellular carcinoma and vitamin K2].
    Mizuta T; Ozaki I
    Clin Calcium; 2015 Nov; 25(11):1645-51. PubMed ID: 26503869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma: agents and concepts for preventing recurrence after curative treatment.
    Schlitt HJ; Schnitzbauer AA
    Liver Transpl; 2011 Nov; 17 Suppl 3():S10-2. PubMed ID: 21850696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemoprevention of hepatocellular carcinoma by acyclic retinoid].
    Nagaki M; Shimizu M; Moriwaki H
    Nihon Shokakibyo Gakkai Zasshi; 2008 Jun; 105(6):802-7. PubMed ID: 18525185
    [No Abstract]   [Full Text] [Related]  

  • 20. Maintenance interferon for chronic hepatitis C: more issues than answers?
    Everson GT
    Hepatology; 2000 Aug; 32(2):436-8. PubMed ID: 10915756
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.